Lawrence Flechner

2.2k total citations · 1 hit paper
19 papers, 1.8k citations indexed

About

Lawrence Flechner is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, Lawrence Flechner has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Rheumatology. Recurrent topics in Lawrence Flechner's work include Growth Hormone and Insulin-like Growth Factors (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Lawrence Flechner is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Lawrence Flechner collaborates with scholars based in United States, Japan and Malaysia. Lawrence Flechner's co-authors include Marc Montminy, Wu Xu, Fayçal Boussouar, Susan Hedrick, Seung‐Hoi Koo, Xinmin Zhang, Shawn Jeffries, Paul K. Brindle, Robert A. Screaton and Hiroshi Takemori and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Molecular Cell.

In The Last Decade

Lawrence Flechner

18 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

2005 815 citations Seung‐Hoi Koo, Lawrence Flechner et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Flechner United States	14	1.2k	430	265	242	163	19	1.8k
Qiangrong Liang United States	22	2.0k 1.6×	303 0.7×	214 0.8×	167 0.7×	255 1.6×	41	2.7k
Joseph L. Messina United States	24	1.0k 0.8×	279 0.6×	322 1.2×	491 2.0×	168 1.0×	76	1.8k
Xin Tong United States	25	876 0.7×	206 0.5×	311 1.2×	155 0.6×	122 0.7×	58	1.7k
Fumihiko Hakuno Japan	26	1.3k 1.0×	218 0.5×	345 1.3×	516 2.1×	190 1.2×	92	2.0k
Nicola Perrotti Italy	30	1.4k 1.1×	352 0.8×	181 0.7×	592 2.4×	228 1.4×	92	2.4k
Eiji Yoshihara Japan	22	1.3k 1.1×	650 1.5×	312 1.2×	299 1.2×	248 1.5×	54	2.3k
Stefan Lehr Germany	25	780 0.6×	325 0.8×	260 1.0×	201 0.8×	124 0.8×	59	1.6k
N. Gregersen Denmark	33	2.0k 1.6×	490 1.1×	496 1.9×	251 1.0×	120 0.7×	104	3.1k
Björn Friedrich Germany	23	1.3k 1.0×	278 0.6×	776 2.9×	345 1.4×	214 1.3×	40	2.4k
Mary Wohltmann United States	22	827 0.7×	310 0.7×	235 0.9×	146 0.6×	98 0.6×	29	1.5k

Countries citing papers authored by Lawrence Flechner

Since Specialization

Citations

This map shows the geographic impact of Lawrence Flechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Flechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Flechner more than expected).

Fields of papers citing papers by Lawrence Flechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Flechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Flechner. The network helps show where Lawrence Flechner may publish in the future.

Co-authorship network of co-authors of Lawrence Flechner

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Flechner. A scholar is included among the top collaborators of Lawrence Flechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Flechner. Lawrence Flechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Shalom‐Barak, Tali, Lawrence Flechner, Suyeon Kim, et al.. (2018). Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ–Retinoid X Receptor α Coactivator. Molecular and Cellular Biology. 38(9). 8 indexed citations

2.

Chi, Thomas, Man Su Kim, Sven Lang, et al.. (2015). A Drosophila Model Identifies a Critical Role for Zinc in Mineralization for Kidney Stone Disease. PLoS ONE. 10(5). e0124150–e0124150. 66 indexed citations

3.

Flechner, Lawrence, James Smith, Patrick Treseler, & John Maa. (2014). Vasal Injury During Inguinal Herniorrhaphy: A Case Report and Review of the Literature. The Permanente Journal. 18(4). 85–88.

4.

Blaschko, Sarah D., Lawrence Flechner, G. Snell, et al.. (2012). 2082 STRONTIUM SUBSTITUTION FOR CALCIUM IN LITHOGENESIS. The Journal of Urology. 187(4S). 2 indexed citations

5.

Blaschko, Sarah D., Joe Miller, Thomas Chi, et al.. (2012). Microcomposition of Human Urinary Calculi Using Advanced Imaging Techniques. The Journal of Urology. 189(2). 726–734. 26 indexed citations

6.

Blaschko, Sarah D., Thomas Chi, Joe Miller, et al.. (2012). Strontium Substitution for Calcium in Lithogenesis. The Journal of Urology. 189(2). 735–739. 32 indexed citations

7.

Flechner, Lawrence, et al.. (2011). Understanding results: P-values, confidence intervals, and number need to treat. Indian Journal of Urology. 27(4). 532–532. 18 indexed citations

8.

Flechner, Lawrence, et al.. (2011). CREB Is Activated by Muscle Injury and Promotes Muscle Regeneration. PLoS ONE. 6(9). e24714–e24714. 69 indexed citations

9.

Smith, James F., A.W. Shindel, Yun-Ching Huang, et al.. (2010). Pentoxifylline treatment and penile calcifications in men with Peyronie's disease. Asian Journal of Andrology. 13(2). 322–325. 46 indexed citations

10.

Duclos, Alain, Lawrence Flechner, Charles Faiman, & Stuart M. Flechner. (2006). Post-Transplant Diabetes Mellitus. Drugs & Aging. 23(10). 781–793. 6 indexed citations

11.

Araki, Motoo, Stuart M. Flechner, Lawrence Flechner, et al.. (2006). Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Receiving Calcineurin or mTOR Inhibitor Drugs. Transplantation. 81(3). 335–341. 61 indexed citations

12.

Koo, Seung‐Hoi, Lawrence Flechner, Ling Qi, et al.. (2005). The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 437(7062). 1109–1114. 815 indexed citations breakdown →

13.

Best, Jennifer L., Carlos Amezcua, B Mayr, et al.. (2004). Identification of small-molecule antagonists that inhibit an activator:coactivator interaction. Proceedings of the National Academy of Sciences. 101(51). 17622–17627. 177 indexed citations

14.

Conkright, Michael D., Ernesto Guzmán, Lawrence Flechner, et al.. (2003). Genome-Wide Analysis of CREB Target Genes Reveals A Core Promoter Requirement for cAMP Responsiveness. Molecular Cell. 11(5). 1417–1417. 11 indexed citations

15.

Conkright, Michael D., Ernesto Guzmán, Lawrence Flechner, et al.. (2003). Genome-Wide Analysis of CREB Target Genes Reveals A Core Promoter Requirement for cAMP Responsiveness. Molecular Cell. 11(4). 1101–1108. 215 indexed citations

16.

Li, Weiqun, et al.. (2000). Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.. PubMed. 60(14). 3909–15. 24 indexed citations

17.

Soon, Lilian, Lawrence Flechner, J. Silvio Gutkind, et al.. (1999). Insulin-Like Growth Factor I Synergizes with Interleukin 4 for Hematopoietic Cell Proliferation Independent of Insulin Receptor Substrate Expression. Molecular and Cellular Biology. 19(5). 3816–3828. 46 indexed citations

18.

Li, Weiqun, Jiachang Zhang, Lawrence Flechner, et al.. (1999). Protein kinase C-α overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene. 18(47). 6564–6572. 99 indexed citations

19.

Li, Weiqun, Yixing Jiang, Jiachang Zhang, et al.. (1998). Protein Kinase C-δ Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation. Molecular and Cellular Biology. 18(10). 5888–5898. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact